Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial Cássio Mallmann; Thizá Maria Bianchi Galiotto; Michele Salibe de Oliveira; Rafael Barberena Moraes;

Ten take-home messages on vasopressin use in critically ill patients Ricard Ferrer; Pedro Castro; Carol Lorencio; Josman Monclou; Pilar Marcos; Ana Ochagavia; Juan Carlos Ruíz-Rodríguez; Josep Trenado; Christian Villavicencio; Juan Carlos Yébenes; Lluís Zapata;

Fármacos vasoactivos en el tratamiento del shock séptico D. Andaluz-Ojeda; M.L. Cantón-Bulnes; C. Pey Richter; J. Garnacho-Montero;